Chapter 51: Anxiety Disorders in Children

Anxiety disorders represent the most prevalent psychiatric condition affecting children and adolescents, with lifetime prevalence rates exceeding 30 percent and significant potential to escalate into mood disorders, substance abuse, and additional psychiatric complications if left untreated. This chapter provides comprehensive coverage of the major anxiety disorders in pediatric populations, including separation anxiety disorder, selective mutism, specific phobias, social anxiety disorder, generalized anxiety disorder, and panic disorder. Clinical manifestations differ substantially based on developmental stage, with younger children typically displaying somatic symptoms, irritability, emotional dysregulation, and resistance to separation, while older children and adolescents more commonly experience intrusive worry, perfectionism, behavioral avoidance, and panic attacks. Underlying biological and psychosocial risk factors include inherited genetic predisposition, temperamental characteristics such as behavioral inhibition, maladaptive parenting patterns that emphasize control or overprotection, traumatic experiences and peer victimization, insecure attachment relationships, and dysregulation within the amygdala, hippocampus, and hypothalamic-pituitary-adrenal axis. Early recognition proves critical because untreated anxiety significantly impairs academic functioning, social relationships, and family dynamics while frequently co-occurring with attention-deficit hyperactivity disorder, depressive disorders, and learning disabilities. Comprehensive assessment incorporates developmental history, validated rating instruments, and careful differentiation between normative developmental fears and pathological anxiety. Evidence-based treatment combines psychotherapeutic and pharmacological approaches, with cognitive behavioral therapy representing the gold standard intervention through exposure-based techniques, relaxation strategies, and cognitive restructuring, complemented by parent-focused interventions that reduce accommodation of avoidance patterns. Selective serotonin reuptake inhibitors including fluoxetine, sertraline, and fluvoxamine demonstrate robust efficacy in controlled trials, with combined pharmacotherapy and psychotherapy yielding superior outcomes for moderate to severe presentations. Prognosis depends on treatment engagement, with many children experiencing significant improvement, though persistent untreated anxiety heightens vulnerability to chronic conditions, depression, and suicidal ideation in later development.